Literature DB >> 6262538

Synthesis of murine mammary tumor viral proteins in vitro.

G C Sen, J Racevskis, N H Sarkar.   

Abstract

The coding potential of murine mammary tumor viral genomic RNA was investigated by in vitro translation of various size classes of RNAs isolated from the virions. The major products of translation of full-size 35S polyadenylylated virion RNA were gag-related polyproteins of 75,000, 105,000, and 180,000 daltons (P75, P105, and P180, respectively). Studies on the kinetics of translation of these three proteins established that they were synthesized independently and that the smaller proteins were not post-translational cleavage products of the larger proteins. Tryptic peptide mapping showed that almost all of the P75 sequences were contained within P105 and almost all of the P105 sequences were contained within P180. The syntheses of all three proteins were inhibited by m7GTP, indicating that they were translated from capped mRNA's. Although a 24S polyadenylylated RNA had been identified as the intracellular mRNA for env precursor polyprotein, no such protein could be translated from the 24S polyadenylylated RNA isolated from the virions. However, translation of a 14S size class of polyadenylylated virion yielded four prominent proteins of about 36,000, 23,000, 21,000, and 20,000 daltons. These proteins were unrelated to murine mammary tumor viral structural proteins, as suggested from tryptic peptide mapping and immunoprecipitation data. They might be the products of an as-yet-unidentified gene located near the 3' terminus of the murine mammary tumor viral genomic RNA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262538      PMCID: PMC171094     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Nonspecific effect of m7GMP on protein-RNA interactions.

Authors:  N Sonenberg; A J Shatkin
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

2.  In vitro translation of Harvey murine sarcoma virus RNA.

Authors:  W P Parks; E M Scolnick
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

3.  Identification of a polypeptide encoded by the avian sarcoma virus src gene.

Authors:  A F Purchio; E Erikson; J S Brugge; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Synthesis and processing of precursor polypeptides to murine mammary tumor virus structural proteins.

Authors:  J Racevskis; N H Sarkar
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

5.  Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins.

Authors:  G Schochetman; C W Long; S Oroszlan; L Arthur; D L Fine
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

Review 6.  Retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Polypeptides of the mouse mammary tumor virus. I. Characterization of two group-specific antigens.

Authors:  N H Sarkar; A S Dion
Journal:  Virology       Date:  1975-04       Impact factor: 3.616

8.  Structure and processing of the mouse mammary tumor virus glycoprotein precursor pr73env.

Authors:  C Dickson; M Atterwill
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

9.  Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family.

Authors:  J H Elder; F C Jensen; M L Bryant; R A Lerner
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

10.  Polyproteins related to the major core protein of mouse mammary tumor virus.

Authors:  C Dickson; M Atterwill
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

View more
  11 in total

Review 1.  Factors controlling the expression of mouse mammary tumour virus.

Authors:  W H Günzburg; B Salmons
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Regulation of synthesis and turnover of an interferon-inducible mRNA.

Authors:  J Kusari; G C Sen
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

3.  Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins.

Authors:  T Jacks; K Townsley; H E Varmus; J Majors
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  Conservation of protein coding potential in the long terminal repeats of exogenous and endogenous mouse mammary tumor viruses.

Authors:  G Peters; R Smith; S Brookes; C Dickson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Further evidence for the protein coding potential of the mouse mammary tumor virus long terminal repeat: nucleotide sequence of an endogenous proviral long terminal repeat.

Authors:  L A Donehower; B Fleurdelys; G L Hager
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Expression of the protein product of the mouse mammary tumor virus long terminal repeat gene in phorbol ester-treated mouse T-cell-leukemia cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region.

Authors:  B Salmons; V Erfle; G Brem; W H Günzburg
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Expression of interferon-inducible genes in RD-114 cells.

Authors:  J Kusari; R K Tiwari; R Kumar; G C Sen
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

9.  Asymmetric transcription of mouse mammary tumor virus genes in vivo and in vitro.

Authors:  R S Prewitt; L D Washington; M R Stallcup
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

10.  Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product.

Authors:  D A Wheeler; J S Butel; D Medina; R D Cardiff; G L Hager
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.